EPISODE · Aug 31, 2026 · 37 MIN
Managing Cardiovascular-Kidney-Metabolic (CKM) Syndrome in Patient Care
from CEimpact Podcast · host CEimpact
Cardiovascular-Kidney-Metabolic (CKM) syndrome recognizes the interconnected relationship among cardiovascular disease, kidney disease, obesity, diabetes, and other metabolic risk factors that contribute to long-term health outcomes. The first-ever CKM clinical practice guideline introduces a framework for risk assessment, staging, prevention, and management, emphasizing early identification and coordinated care across disease states. You will be better prepared to recognize CKM syndrome, understand its implications for patient care, and support evidence-based strategies to reduce cardiovascular, kidney, and metabolic risk.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTChristine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy Practice and Clinical PharmacistMidwestern UniversityGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates- Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the stages and key components of cardiovascular-kidney-metabolic syndrome.2. Explain evidence-based strategies for identifying and managing patients at risk for CKM syndrome.Christine Schumacher is a Speaker and Advisory Board Member for Abbott. All relevant financial relationships have been mitigated. 0.075 CEU/0.75 HrUAN: 0107-0000-26-315-H01-PInitial release date: 8/31/2026Expiration date: 8/31/2029Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
Embed this episode
What this episode covers
Cardiovascular-Kidney-Metabolic (CKM) syndrome recognizes the interconnected relationship among cardiovascular disease, kidney disease, obesity, diabetes, and other metabolic risk factors that contribute to long-term health outcomes. The first-ever CKM clinical practice guideline introduces a framework for risk assessment, staging, prevention, and management, emphasizing early identification and coordinated care across disease states. You will be better prepared to recognize CKM syndrome, und...
Ready to play
Managing Cardiovascular-Kidney-Metabolic (CKM) Syndrome in Patient Care
No transcript for this episode yet
Similar Episodes
No similar episodes found.